Bray Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $850K | Sell |
4,786
-330
| -6% | -$60.7K | 0.23% | 83 |
|
|
2024
Q3 | $1.01M | Hold |
5,116
| – | – | 0.25% | 81 |
|
|
2024
Q2 | $877K | Hold |
5,116
| – | – | 0.22% | 83 |
|
|
2024
Q1 | $932K | Hold |
5,116
| – | – | 0.24% | 85 |
|
|
2023
Q4 | $793K | Hold |
5,116
| – | – | 0.22% | 89 |
|
|
2023
Q3 | $763K | Hold |
5,116
| – | – | 0.23% | 86 |
|
|
2023
Q2 | $689K | Hold |
5,116
| – | – | 0.21% | 92 |
|
|
2023
Q1 | $815K | Hold |
5,116
| – | – | 0.24% | 87 |
|
|
2022
Q4 | $827K | Hold |
5,116
| – | – | 0.26% | 88 |
|
|
2022
Q3 | $687K | Hold |
5,116
| – | – | 0.22% | 94 |
|
|
2022
Q2 | $784K | Hold |
5,116
| – | – | 0.23% | 93 |
|
|
2022
Q1 | $829K | Hold |
5,116
| – | – | 0.21% | 96 |
|
|
2021
Q4 | $693K | Hold |
5,116
| – | – | 0.17% | 99 |
|
|
2021
Q3 | $552K | Hold |
5,116
| – | – | 0.14% | 103 |
|
|
2021
Q2 | $576K | Sell |
5,116
-102
| -2% | -$11.5K | 0.15% | 103 |
|
|
2021
Q1 | $565K | Hold |
5,218
| – | – | 0.16% | 101 |
|
|
2020
Q4 | $559K | Hold |
5,218
| – | – | 0.16% | 99 |
|
|
2020
Q3 | $457K | Hold |
5,218
| – | – | 0.16% | 99 |
|
|
2020
Q2 | $512K | Buy |
5,218
+400
| +8% | +$35.2K | 0.2% | 93 |
|
|
2020
Q1 | $367K | Hold |
4,818
| – | – | 0.17% | 97 |
|
|
2019
Q4 | $427K | Sell |
4,818
-350
| -7% | -$29.1K | 0.15% | 103 |
|
|
2019
Q3 | $391K | Hold |
5,168
| – | – | 0.15% | 103 |
|
|
2019
Q2 | $376K | Sell |
5,168
-698
| -12% | -$54.9K | 0.14% | 109 |
|
|
2019
Q1 | $473K | Buy |
5,866
+80
| +1% | +$6.54K | 0.2% | 95 |
|
|
2018
Q4 | $533K | Hold |
5,786
| – | – | 0.27% | 82 |
|
|
2018
Q3 | $547K | Hold |
5,786
| – | – | 0.24% | 83 |
|
|
2018
Q2 | $536K | Hold |
5,786
| – | – | 0.25% | 78 |
|
|
2018
Q1 | $548K | Buy |
5,786
+149
| +3% | +$16.4K | 0.26% | 76 |
|
|
2017
Q4 | $545K | Sell |
5,637
-322
| -5% | -$30.3K | 0.26% | 76 |
|
|
2017
Q3 | $530K | Sell |
5,959
-145
| -2% | -$11K | 0.28% | 72 |
|
|
2017
Q2 | $443K | Sell |
6,104
-4,000
| -40% | -$269K | 0.24% | 76 |
|
|
2017
Q1 | $658K | Sell |
10,104
-22,144
| -69% | -$1.39M | 0.37% | 59 |
|
|
2016
Q4 | $2.02M | Sell |
32,248
-365
| -1% | -$22.3K | 1.21% | 36 |
|
|
2016
Q3 | $2.06M | Buy |
32,613
+307
| +1% | +$19.9K | 1.24% | 35 |
|
|
2016
Q2 | $2M | Buy |
32,306
+1,980
| +7% | +$121K | 1.24% | 33 |
|
|
2016
Q1 | $1.73M | Sell |
30,326
-2,052
| -6% | -$114K | 1.5% | 32 |
|
|
2015
Q4 | $1.92M | Sell |
32,378
-5,990
| -16% | -$345K | 1.22% | 30 |
|
|
2015
Q3 | $2.09M | Sell |
38,368
-467
| -1% | -$30.4K | 1.33% | 23 |
|
|
2015
Q2 | $2.61M | Sell |
38,835
-660
| -2% | -$43.1K | 1.5% | 14 |
|
|
2015
Q1 | $2.31M | Buy |
39,495
+15,095
| +62% | +$912K | 1.37% | 20 |
|
|
2014
Q4 | $1.6M | Buy |
+24,400
| New | +$1.54M | 1.04% | 32 |
|
Other funds holding ABBV
Bray Capital Advisors's ABBV Position: Q4 2024 in Review
Bray Capital Advisors reduced its AbbVie (ABBV) stake by 6.5% in Q4 2024, selling an estimated $60.7K and leaving 4,786 shares worth $850K. The position accounts for 0.23% of the portfolio, ranked #83.
Bray Capital Advisors first reported a position in ABBV in Q4 2014 and has held it in 41 quarters since. The position peaked at $2.61M in Q2 2015. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.
- Bray Capital Advisors held 4,786 shares of AbbVie worth $850K as of Q4 2024.
- Bray Capital Advisors sold 330 AbbVie shares in Q4 2024, an estimated $60.7K.
- AbbVie made up 0.23% of Bray Capital Advisors's portfolio in Q4 2024, its #83 holding.
- Bray Capital Advisors first reported a position in AbbVie in Q4 2014 and has held it in 41 quarters since.
- Bray Capital Advisors's AbbVie position peaked at $2.61M in Q2 2015.
- 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.
Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.